Titre :

Influence of glycaemic control on the outcomes of patients treated by intravenous thrombolysis for cerebral ischaemia

Auteur(s) :

Litke, Rachel [Auteur]
Moulin, Solene [Auteur]
Cordonnier, Charlotte [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U1171
fontaine, pierre [Auteur]
Génomique Intégrative et Modélisation des Maladies Métaboliques (EGID) - UMR 8199
LEYS, Didier [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U1171
Troubles cognitifs dégénératifs et vasculaires - U1171

Titre de la revue :

Journal of Neurology

Nom court de la revue :

J. Neurol.

Numéro :

262

Pagination :

2504-2512

Date de publication :

2015-11-01

ISSN :

0340-5354

Mot(s)-clé(s) :

Mesh:Administration
Mesh:Intravenous
Mesh:Aged
Mesh:80 and over
Mesh:Blood Glucose/analysis
Mesh:Brain Ischemia*/drug therapy
Mesh:Fibrinolytic Agents/administration & dosage
Mesh:Glucose Metabolism Disorders*/drug therapy
Mesh:Hypoglycemic Agents/pharmacology*
Mesh:Middle Aged
Mesh:Tissue Plasminogen Activator/pharmacology*
Mesh:Brain Ischemia*/epidemiology
Mesh:Follow-Up Studies
Mesh:Glucose Metabolism Disorders*/epidemiology
Mesh:Retrospective Studies
Mesh:Outcome Assessment (Health Care)*
Mesh:Humans
Mesh:Insulin/administration & dosage
Mesh:Insulin/pharmacology*
Mesh:Fibrinolytic Agents/pharmacology*
Mesh:Comorbidity
Mesh:Blood Glucose/drug effects
Mesh:Female
Mesh:Male
Mesh:Hypoglycemic Agents/administration & dosage
Mesh:Glucose Metabolism Disorders*/blood
Mesh:Aged
Mesh:Tissue Plasminogen Activator/administration & dosage
Mesh:Brain Ischemia*/blood
Cerebral haemorrhage
Serum glucose level
Glycaemic control
Diabetes mellitus
Ischaemic stroke
Cerebral ischaemia
Thrombolysis
Symptomatic haemorrhagic transformation
Outcome

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Whether the glycaemic control during the first hours of cerebral ischaemia treated by thrombolysis influences outcomes remains unsettled. We aimed at evaluating the quality of the glycaemic control and whether patients ...
Lire la suite >Whether the glycaemic control during the first hours of cerebral ischaemia treated by thrombolysis influences outcomes remains unsettled. We aimed at evaluating the quality of the glycaemic control and whether patients with well-controlled glycaemia after thrombolysis for acute cerebral ischaemia have better outcomes. We retrospectively analysed data prospectively collected in consecutive stroke patients who received i.v. thrombolysis at the Lille University Hospital. Patients with glycaemia >1.6 g/l (8.9 mmol/l) at any point during the first 48 h received insulin. We used 2 definitions of well controlled glycaemia: (i) "well controlled 100 %" when 100 % glycaemia were <1.6 g/l (8.9 mmol/l), and (ii) "well controlled 70 %" when at least 70 % glycaemia were <1.6 g/l (8.9 mmol/l). The outcome measures at 3 months were (1) independence [modified Rankin scale (mRS) score 0 or 1], (2) absence of handicap (mRS 0-2), (3) death, and (4) symptomatic intracerebral haemorrhage (sICH). Of 875 consecutive patients, 657 (75.2 %) were considered as well controlled with a threshold at 100 % and 736 (84.2 %) with a threshold at 70 %. The glycaemic control was not independently associated with any of the four outcome measures. In patients treated by insulin, hypoglycaemic events were rare (2.1 % of all patients) and of moderate intensity [>0.5 g/l (2.8 mmol/l)]. The quality of the glycaemic control was not associated with outcomes in patients treated by thrombolysis. A possible explanation is that the glycaemic control after thrombolysis has minor influence compared with glycaemic control before thrombolysis when the artery is not yet re-open and the penumbra area at maximum.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Inserm
Université de Lille
CHU Lille
Institut Pasteur de Lille
CNRS

Collections :

• Génomique Intégrative et Modélisation des Maladies Métaboliques (EGID) - UMR 8199
• Lille Inflammation Research International Center (LIRIC) - U995
• Troubles cognitifs dégénératifs et vasculaires - U1171

Équipe(s) de recherche :

Glycation from inflammation to aging

Date de dépôt :

2019-03-01T15:14:04Z